ANGPT2 and glioblastoma: More recently, the groups of Plate and Reiss showed that blockade of VEGF, ANGPT2, and PD-1 extended the survival of GBM-bearing mice in comparison to anti-VEGF and anti-ANGPT2 alone [183].